US SB1688 | 2017-2018 | 115th Congress

Status

Spectrum: Partisan Bill (Democrat 35-1)
Status: Introduced on August 1 2017 - 25% progression, died in committee
Action: 2017-08-01 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Empowering Medicare Seniors to Negotiate Drug Prices Act of 2017 This bill amends title XVIII (Medicare) of the Social Security Act to allow the Centers for Medicare & Medicaid Services to: (1) negotiate drug prices under the Medicare prescription drug benefit, and (2) institute a price structure for the reimbursement of drugs covered under the benefit.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Empowering Medicare Seniors to Negotiate Drug Prices Act of 2017

Sponsors


History

DateChamberAction
2017-08-01SenateRead twice and referred to the Committee on Finance.

Same As/Similar To

HB242 (Related) 2017-01-25 - Referred to the Subcommittee on Health.
HB1775 (Related) 2017-04-05 - Referred to the Subcommittee on Health.
HB1776 (Related) 2017-04-05 - Referred to the Subcommittee on Health.
SB41 (Related) 2017-01-05 - Read twice and referred to the Committee on Finance.
SB348 (Related) 2017-02-09 - Read twice and referred to the Committee on Finance.
SB771 (Related) 2017-03-29 - Read twice and referred to the Committee on Finance.
SB1511 (Related) 2017-06-29 - Read twice and referred to the Committee on Finance.
SB2708 (Related) 2018-04-18 - Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S2265-2266)

Subjects


US Congress State Sources


Bill Comments

feedback